Zhangzhou Pientzehuang Pharmaceutical Future Growth
Future criteria checks 2/6
Zhangzhou Pientzehuang Pharmaceutical is forecast to grow earnings and revenue by 16.6% and 12.5% per annum respectively. EPS is expected to grow by 16.6% per annum. Return on equity is forecast to be 21.7% in 3 years.
Key information
16.6%
Earnings growth rate
16.6%
EPS growth rate
Pharmaceuticals earnings growth | 18.6% |
Revenue growth rate | 12.5% |
Future return on equity | 21.7% |
Analyst coverage | Good |
Last updated | 12 Aug 2024 |
Recent future growth updates
Recent updates
Subdued Growth No Barrier To Zhangzhou Pientzehuang Pharmaceutical., Ltd's (SHSE:600436) Price
Jul 12These 4 Measures Indicate That Zhangzhou Pientzehuang Pharmaceutical (SHSE:600436) Is Using Debt Safely
May 27Zhangzhou Pientzehuang Pharmaceutical., Ltd's (SHSE:600436) Business Is Yet to Catch Up With Its Share Price
Feb 28Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 14,586 | 4,492 | 4,506 | 4,232 | 10 |
12/31/2025 | 12,963 | 3,843 | 3,851 | 3,360 | 11 |
12/31/2024 | 11,211 | 3,255 | 2,835 | 2,952 | 6 |
6/30/2024 | 10,664 | 2,978 | 1,116 | 1,220 | N/A |
3/31/2024 | 10,600 | 3,002 | 1,968 | 2,104 | N/A |
12/31/2023 | 10,058 | 2,797 | 2,065 | 2,207 | N/A |
9/30/2023 | 9,678 | 2,825 | 2,918 | 3,082 | N/A |
6/30/2023 | 9,317 | 2,699 | 2,719 | 2,877 | N/A |
3/31/2023 | 8,975 | 2,553 | 6,810 | 7,001 | N/A |
12/31/2022 | 8,694 | 2,472 | 6,698 | 6,873 | N/A |
9/30/2022 | 8,526 | 2,473 | 5,850 | 5,989 | N/A |
6/30/2022 | 8,595 | 2,631 | 5,406 | 5,544 | N/A |
3/31/2022 | 8,368 | 2,556 | 197 | 289 | N/A |
12/31/2021 | 8,022 | 2,432 | 370 | 462 | N/A |
9/30/2021 | 7,553 | 2,354 | 318 | 627 | N/A |
6/30/2021 | 7,113 | 1,922 | 792 | 1,203 | N/A |
3/31/2021 | 6,798 | 1,769 | 1,423 | 1,842 | N/A |
12/31/2020 | 6,511 | 1,672 | 1,048 | 1,467 | N/A |
9/30/2020 | 6,451 | 1,594 | -727 | -520 | N/A |
6/30/2020 | 6,074 | 1,493 | -1,357 | -1,252 | N/A |
3/31/2020 | 5,952 | 1,438 | -1,153 | -1,075 | N/A |
12/31/2019 | 5,722 | 1,374 | -945 | -879 | N/A |
9/30/2019 | 5,522 | 1,332 | 1,544 | 1,626 | N/A |
6/30/2019 | 5,257 | 1,272 | 1,519 | 1,595 | N/A |
3/31/2019 | 5,028 | 1,221 | 795 | 870 | N/A |
12/31/2018 | 4,766 | 1,143 | 538 | 612 | N/A |
9/30/2018 | 4,555 | 1,052 | 26 | 79 | N/A |
6/30/2018 | 4,365 | 991 | 113 | 169 | N/A |
3/31/2018 | 4,076 | 907 | N/A | 641 | N/A |
12/31/2017 | 3,714 | 807 | N/A | 677 | N/A |
9/30/2017 | 3,428 | 730 | N/A | 794 | N/A |
6/30/2017 | 3,101 | 664 | N/A | 654 | N/A |
3/31/2017 | 2,700 | 616 | N/A | 549 | N/A |
12/31/2016 | 2,309 | 536 | N/A | 395 | N/A |
9/30/2016 | 2,180 | 575 | N/A | 407 | N/A |
6/30/2016 | 2,032 | 520 | N/A | 374 | N/A |
3/31/2016 | 1,975 | 497 | N/A | 342 | N/A |
12/31/2015 | 1,886 | 467 | N/A | 306 | N/A |
9/30/2015 | 1,698 | 513 | N/A | 330 | N/A |
6/30/2015 | 1,503 | 474 | N/A | 314 | N/A |
3/31/2015 | 1,455 | 440 | N/A | 298 | N/A |
12/31/2014 | 1,454 | 439 | N/A | 264 | N/A |
9/30/2014 | 1,409 | 373 | N/A | 240 | N/A |
6/30/2014 | 1,446 | 422 | N/A | 251 | N/A |
3/31/2014 | 1,436 | 438 | N/A | 289 | N/A |
12/31/2013 | 1,396 | 430 | N/A | 274 | N/A |
9/30/2013 | 1,348 | 423 | N/A | 217 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 600436's forecast earnings growth (16.6% per year) is above the savings rate (2.9%).
Earnings vs Market: 600436's earnings (16.6% per year) are forecast to grow slower than the CN market (21.9% per year).
High Growth Earnings: 600436's earnings are forecast to grow, but not significantly.
Revenue vs Market: 600436's revenue (12.5% per year) is forecast to grow slower than the CN market (13.4% per year).
High Growth Revenue: 600436's revenue (12.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 600436's Return on Equity is forecast to be high in 3 years time (21.7%)